Biological Information
Background Information:
Voltage-gated calcium channels mediate calcium influx in response to membrane depolarization and regulate intracellular processes such as contraction, secretion, neurotransmission, and gene expression. They are members of a gene superfamily of transmembrane ion channel proteins that includes voltage-gated potassium and sodium channels. Pharmacology of the three families of calcium channels is quite distinct. L-Type calcium channel blockers are used in the therapy of cardiovascular disease. L-type phenylalkylamine channel blockers are used in the treatment of angina and may cause hypotension associated with mild to severe bradycardia; reflex tachycardia may occur if hypotension is marked.
Family:
Ion Channel
Sub Family:
Calcium
Class:
Voltage-Gated
Protein Name:
Cav1.2 (L-type)
Uniprot Number:
Q13936
Gene Name:
CACNA1C
Gene ID:
775
Gene Aliases:
Cav1.2|CACH2|CACN2|TS|LQT8
Organism:
Rat
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
This assay measures binding of [³H]Diltiazem to calcium channel L-Type benzothiazepine receptors. Brains (except cerebella) of male Wistar derived rats weighing 175 ± 25 g are prepared in modified Tris-HCl pH 7.4 buffer using standard techniques. A 0.5 mg‡ aliquot of membrane protein is incubated with 2 nM [³H]Diltiazem for 180 minutes at 4℃. Non-specific binding is estimated in the presence of 10 µM Diltiazem. Membranes are filtered and washed 3 times and the filters are counted to determine [³H]Diltiazem specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.
Ligand:
[³H] Diltiazem
Ligand Kd (nM):
16
Ligand Concentration:
2 nM
Non Specific:
10 µM Diltiazem
Incubation:
180 min at 4°C
Control Inhibitor:
Diltiazem
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Cardiovascular
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS